• Ibrexafungerp Against Resistant Candida auris

  2026-08-30

  The reference study shows that ibrexafungerp retained in vitro activity against fluconazole-resistant Candida auris and improved outcomes in a neutropenic mouse model even when therapy was delayed. Its oral triterpenoid mechanism expands glucan-targeting strategies beyond injectable echinocandins and provides a useful framework for resistant Candida research.

• IR-1061: Designing Reliable OTN-NIR Assays

  2026-08-29

  IR-1061 is a near infrared fluorescent dye for OTN-NIR imaging, but assay performance depends on formulation, storage, and optical controls. This guide translates polymer-micelle evidence into practical decisions for reproducible biomedical and deep-tissue imaging workflows.

• Dietary Arachidonic Acid and Humoral Immunity

  2026-08-28

  A 2025 study reports that dietary arachidonic acid enhances rabies vaccine-induced neutralizing antibodies in mice and accelerates protective antibody development in human volunteers. The work identifies lymph-node enrichment and a prostaglandin I2–cAMP–PKA pathway linking dietary lipid metabolism to CD86 expression and activation-induced cytidine deaminase in B cells.

• a-MSH, amide: A Better Melanogenesis Control

  2026-08-28

  a-MSH, amide provides a defined melanocortin stimulus for separating receptor-driven melanin synthesis from downstream inhibition. This article explains how to use alpha-melanocyte-stimulating hormone amide as an assay anchor, interpret CREB/MITF findings, and connect pigmentation with inflammation research.

• Catalpol in Alzheimer’s Disease: Mechanisms and Evidence

  2026-08-27

  The 2022 reference review presents catalpol as a multitarget iridoid glycoside with antioxidant, anti-inflammatory, antiapoptotic, and mitochondrial-protective effects relevant to Alzheimer’s disease. Its main contribution is an integrated mechanistic framework, while its preclinical evidence also highlights the need for standardized models, dose comparisons, and clinical validation.

• Pyridostatin TFA: G-Quadruplex Research Guide

  2026-08-27

  Pyridostatin is a synthetic G-quadruplex stabilizer used to study telomere dysfunction and cancer cell growth. Pyridostatin TFA is the commonly used salt form, with vendor-reported activity in human cell models and defined handling parameters.

• (1S,3R)-RSL3: GPX4 Inhibitor Guide

  2026-08-26

  RSL3 is a direct glutathione peroxidase 4 inhibitor that triggers ferroptosis by weakening cellular protection against lipid peroxidation. This guide connects its GPX4 mechanism, RAS-linked preclinical activity, formulation limits, and evidence-based workflow controls.

• Doxorubicin HCl: A Translational Assay Framework

  2026-08-26

  Doxorubicin hydrochloride is more than a cytotoxic agent: it is a powerful tool for separating DNA damage, energy stress, tumor-cell apoptosis, and cardiac injury. This article presents an assay-centered framework grounded in recent ferroptosis and cardiotoxicity findings.

• Sisomicin Workflows for In Vitro Antibacterial Testing

  2026-08-25

  Sisomicin provides a practical benchmark for susceptibility testing across clinically relevant Gram-negative and Gram-positive organisms. This guide translates primary isolate data into reproducible assay setup, resistance-aware comparisons, and troubleshooting decisions for infection research.

• TMEM16F in Kupffer Cells Protects Against Listeria

  2026-08-25

  This 2024 Advanced Science study identifies Kupffer cell-expressed TMEM16F, rather than T- or B-cell TMEM16F, as a key determinant of host protection against Listeria monocytogenes. By combining cell type-specific mouse genetics with plasma-membrane injury, inflammation, and liver-metabolism analyses, the work connects lipid scrambling and membrane repair to control of bacterial tissue damage.

• Cyclopamine: Hedgehog Signaling Inhibitor Workflows

  2026-08-24

  Cyclopamine enables controlled Smoothened perturbation across cancer, developmental, and olfactory biology experiments. This practical guide connects dose-response screening with apoptosis, pathway validation, electrophysiology, and behavior while highlighting formulation, exposure, and interpretation safeguards.

• Zosuquidar: A PK-Aware MDR Assay Framework

  2026-08-24

  Zosuquidar and LY335979 are widely used to interrogate P-glycoprotein-mediated multidrug resistance. This article presents a PK-aware framework that connects transporter biology, disease-state variability, and assay interpretation without overstating cross-domain evidence.

• IWP-L6: A Causal Probe of Wnt Metabolism

  2026-08-23

  IWP-L6 is a highly potent Porcupine inhibitor for testing how upstream Wnt production controls downstream metabolism and osteogenic behavior. This article translates recent Wnt–O-GlcNAcylation findings into a rigorous assay strategy spanning pathway, metabolic, ex vivo, and regenerative readouts.

• NSC-23766: Rac GTPase Inhibitor Workflows

  2026-08-22

  NSC-23766 enables causal interrogation of Rac1 activation in breast cancer, endothelial barrier, and metabolic signaling models. This practical guide connects dose design, pathway-specific readouts, and troubleshooting with the emerging lactate–GPR81–FARP1–Rac1 axis.

• Levofloxacin in Cell and Bone Assays

  2026-08-22

  This scenario-driven guide explains how Levofloxacin (SKU B1959) can support reproducible antibacterial, osteoblast, and cartilage-metabolism experiments. It covers assay interpretation, solvent compatibility, exposure design, and practical product-selection criteria for biomedical laboratories.

8051 records 1/537 page Next 12345 下5页 Last page